Trials / Completed
CompletedNCT06153758
Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults
A Phase 1, 4-Part, Open-Label, Randomized Study With A 5-Period, 4 Sequence, Crossover Design to Compare the Single Dose Pharmacokinetics Between Immediate and Modified Release Formulations of Danuglipron Administered Orally to Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to learn how different forms of a study medication called danuglipron are taken into the blood in healthy adults, following single dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danuglipron | Danuglipron oral tablets |
Timeline
- Start date
- 2023-11-27
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2023-12-01
- Last updated
- 2024-10-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06153758. Inclusion in this directory is not an endorsement.